Lenskart vs Titan EyeCare: post-listing eyewear showdown across margins, store reach and business models
Lenskart posts Q2 FY26 revenue of Rs 2,146.6 cr (up 24%) with 19.8% EBITDA margin and 69.2% product margin, powered by in-house manufacturing. Titan EyeCare, prescription-led with 871 stores, logs Rs 215 cr income and just Rs 12 cr segment EBIT. Both flag GST-cut-driven demand delays in a ~Rs 30,000 cr market.
Post-listing comparison of Lenskart and Titan EyeCare across market size, store reach, business models, cost structure and Q2 FY26 results. Lenskart shows stronger margins via in-house manufacturing; Titan is prescription-led. Both flagged GST-cut-driven demand delays.